Orexigen buys U.S. rights to obesity drug from Takeda
 

Orexigen buys U.S. rights to obesity drug from Takeda
(Reuters) - Orexigen Therapeutics Inc said it would pay $60 million to acquire the U.S. rights to its flagship obesity drug from partner Takeda Pharmaceutical Co.


http://rc.feedsportal.com/r/24739482...19/rc/1/rc.img

http://rc.feedsportal.com/r/24739482...19/rc/2/rc.img

http://rc.feedsportal.com/r/24739482...19/rc/3/rc.img

http://da.feedsportal.com/r/24739482...a/sc/19/a2.img
http://adchoice.feedsportal.com/r/24.../sc/19/ach.imghttp://pi.feedsportal.com/r/24739482.../sc/19/a2t.imghttp://pi2.feedsportal.com/r/2473948...sc/19/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...2w:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...2w:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/6niIrfCDhTc